P1622: ANTIPHOSPHOLIPID ANTIBODIES IN CONVALESCENT PLASMA OF DONORS RECOVERED FROM MILD COVID-19
Main Authors: | D. Blickstein, M. Izak, T. Filipovich- Rimon, O. Garach- Jehoshua, N. Rahimi- Levene, E. Shinar, A. Bar- Chaim, M. Koren-Michowitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000849344.70911.19 |
Similar Items
-
Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
by: Naomi Rahimi-Levene, et al.
Published: (2022-01-01) -
Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy.
by: Naomi Rahimi-Levene, et al.
Published: (2022-01-01) -
Recovering Lost Acoustic Spaces: St. Paul's Cathedral and Paul's Churchyard in 1622
by: John Wall
Published: (2014-01-01) -
International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study
by: Fanny Ofek, et al.
Published: (2019-10-01) -
Retrospective analysis of 426 donors of a convalescent collective after mild COVID-19.
by: Tobias Flieder, et al.
Published: (2021-01-01)